(Q40110864)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ann M Stowe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yue Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Ding Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Laurie S Davis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xiangmei Kong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Wendy I White

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ronald Herbst

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Nancy L Monson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

13 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1541-1549

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764035%20AND%20SRC:MED&resulttype=core&format=json

B cells and antibodies in multiple sclerosis pathogenesis and therapy

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Potential impact of B cells on T cell function in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Multiple sclerosis diagnostic criteria: three years later

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Single dose of glycoengineered anti-CD19 antibody (MEDI551) disrupts experimental autoimmune encephalomyelitis by inhibiting pathogenic adaptive immune responses in the bone marrow and spinal cord while preserving peripheral regulatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Gorlin and goltz syndrome: a case report with surgical review

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Shared genetic factors for age at natural menopause in Iranian and European women

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

The encephalitogenic, human myelin oligodendrocyte glycoprotein-induced antibody repertoire is directed toward multiple epitopes in C57BL/6-immunized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

B lymphocytes differentially influence acute and chronic allograft rejection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376

Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501376